Inhaled COVID-19 Vaccine Approved in China as Profits of Vaccine Giant Plummet

By Epoch Times —— Bio and Archives September 17, 2022

Comments | Print This | Subscribe | Email Us

China’s State Drug Administration granted approval of an inhaled COVID-19 vaccine for emergency use as a booster vaccine last week. Vaccine manufacturer CanSino Biologics made the announcement on Sept. 4, saying it had developed and obtained approval for an inhalable COVID-19 vaccine after a proposal by China’s National Health Commission. The vaccine, called Convidecia, uses a recombinant adenovirus that is unable to replicate.-- More...

Epoch Times -- Bio and Archives | Comments

The Epoch Times: “A Fresh Look at Our Changing World”

The Epoch Times is a privately held news media company. The center is in New York, but our network of local reporters throughout the world uncovers stories that are authentically local, yet also globally relevant. Our independence enables us to report widely and present a diversity of opinions.

We have offices in 30 countries across five continents, and our content is published in 17 languages. We are proud to offer print and web editions in Chinese, English, German, French, Spanish, Hebrew, Russian, Japanese, Korean and Indonesian, as well as web versions in Ukrainian, Bulgarian, Romanian, Czech, Slovak, Vietnamese and Swedish.